Member Info for Pingu777

TheTruth are you invested?
There is a finance deal seeing DEV draw down £2m of £10m by the end of August at the latest. At 10p per share. Still cheap.
3yr contract with Lenovo Signed a couple of months back. USA and Canada roll out of careers VR product Via Lenovo is huge and they’ve just announced partnership that’s opened up India and Japan.

7p zone still cheap imo. Figures on roll out expected late summer.

DEV showing their dynamism by pouncing on an opportunity where their tech can be deployed quickly. Be interesting to see numbers as this is rolled out.

Nearly a mill?

Based on current selling patterns what’s anyone best estimate as to when they might conclude the sell down?

Would you want to do a Q&A with the GlobalCo announcement due and not arrived? Pointless. Makes zero sense.

Hemo sharpening their PR game up slowly but surely. Imo we will know before the webinar.

Bit of a challenge as one is ready for human trials and one is still to reach proper drug candidate.

CDX announcement will be a commercial deal with an upfront payment and milestone payments on success on treating humans. It is overdue. My understanding is that GlobalCo ceased all human trials once the Covid outbreak caused lockdowns and it was not safe to start any new trials or continue most existing ones. This risk has now subsided. No more reasons for delay.

It’s coming shortly whether you like it or not.

Tex, are you serious? You think this latest agreement will delay the GlobalCo reveal? But I guess the fact remains the CDX will be ready for human trials phase 1 now. We all know due to its development and validation on our mice means phase 1 trials are likely to be fast tracked compared to regular trials. I expect us to have the dosage spot on already due to our magic mice.

So are you saying the CDX announcement can’t take place?

How about a progress update on the R&D contract with GlobalCo? Will that be held back also?

A little reading up on the company set up would have helped you.

Hemogenyx - Uk company
Immugenyx - New York subsidiary managing the mice
LCC - Belgium subsidiary, in charge of HuPech

Incredibly money flows between them as the labs are at the subsidiaries.

The less I talk the more it goes up! :-)

Just a casual video clarifying the news that HEMO identified two antibodies that work on lupus and that GlobalCo is sufficiently happy enough to take ANOTHER project forward also. Talk about validation. Its ok saying 'its early days yet but we've big pharma giving it the nod. These anitbodies that are tested on our mice quite simply do not have the same failure rate chances as the candidates 'successfully tested' on other mice. Theyre so much more rigorously tested that our chance of success are significantly increased. Our mice tech platform is the future.

Hemo, the minnow, adds another HUGE potential money making drug to its portfolio. Dam right we get a decent rise!

Cheers Barnard.

The option to take 50m shares at 25p within the next 3 years says it all. Sits in line with the Lenovo contract and to even be considered in the agreement it must be seen as potential value. Great sweetener.

Funny you should mention 50p as that is my cautious estimate. With a roll out to come in Asia as well they really will maximise the potential via Lenovo’s distribution Network.

There’s a huge skills gap that the a Government are trying to plug and the funding for a demonstrably successful project could be through the roof. By the end of the year, with strong take up figures, I see DEV attracting a lot of attention from both IIs and government funding. Schools could be getting additional grants to sign up to DEVs tech via VR headsets.

And just to solidify the reality... here’s a link to the headsets (for those who haven’t already seen it). The game is indeed afoot.

https://support.lenovo.com/gb/en/solutions/ht509874

GlobalCo will be a big deal whomever it is. Covid not going anywhere sadly and until a working vaccine is produced (if even possible) then antibody treatment and regular testing will have a significant part to play.

HEMOs ApbHC mice are a biodefense platform in their own right. We will have been amongst the fastest responders to the pandemic. We know we can quickly build a isolate antibodies, build a disease model to test them on and prove up efficacy and toxicology on our GVH-free mice. The results should be compelling. I think we will know soon.

From a corporate perspective we've worked on it and we've found we have had success with modelling the virus and isolating antibodies then suddenly is a great 'quick win'.

Think about it. The other projects take time to develop and perfect then you come across something you can deliver on in months. We have been on a biodefense platform since last year with the mice so why wouldn't be in a position to attack covid in a live exercise!!!

Although long term investors have continually played down HEMOs covid play I am starting to get the feeling we might just have something that can be commercialised for Covid. Anyone else been thinking this?

Whilst talk of the GlobalCo announcement dominates the horizon and what the amazing CDX might be worth as it moves to human trials, we are still working on a COVID antibody risk rating test that could maybe act as a traffic light assessment on an individuals prevalence to get seriously sick from Covid. This would be a serious breakthrough! With extra funding now available we have been told that projects such as this can be significantly speeded up so is it fair to assume the historic timescales on delivering on project developments will be significantly reduced?

Vlad has a passion for saving lives and helping humanity. I believe he's thrown the kitchen sink at this and based on our track record of successful milestones I can see us producing the goods once again on the covid project and sooner rather than later.

Although we announced the commencement of the covid project in April I believe we have been working on it much longer. I suspect news on this front could well be imminent. Surely you would want to release it with a healthy gap between it and the GlobalCo announcement for full effect?

I think the tech work. The trial suggests it works and in a business environment. The challenge is getting clients spending the dosh. This is where the consortium and their contacts come in.

Current legislate suggest there’ll be around 25% attendance inside pubs, stadiums, gigs, etc. If this app can record and prove people’s ‘status’ for Covid. There’ll be a scramble.

Need to partner with a testing kit provider.

I forgot about that! Gin and tonics have a memory removal aspect! Sorry!

Can remember now why I was removing myself now after reading through today’s posts just now!

I’ll leave you to your constructive discussions.

I’m interested to hear what timescale people have in terms of their exit plan? Surely if you’re holding long enough the daily price fluctuations on no material make no difference? I’m happy to keep mine until the end of next year by which point a lot of the key milestones will be realised imo.

Ideally I’d like us to be multibagging from here by the end of the year. In fact, I reckon within 2 months from now we will be treble this SP.

So how long are you guys in for?

Cheers likey, very lucky timing!

We will see what tomorrow brings Paul. Will be an interesting day that’s for sure!

Hi I’ve just bought in this afternoon.

If you have a big holding and are in the midst of selling them all then my understanding was you don’t need to. Outfit until you’ve finished your block sell. So this would indicate M&G have finished up?

Also, isn’t the point that the market was saturated with this large number of shares and yet they weren’t just absorbed but the price went up throughout the process of the sale? So without that amount of shares being sold then where do buyers get their shares from? Market mechanics would say the price would go up as a result?

And what if this RNS triggers increased buying and overall volume?

Seems like tomorrow night be an interesting day to me.

Scart no offence to you.

Indeed, posting done.

Leido aren’t a proper bio who specialise In cancer and autoimmune treatment . Tell me why it might be them?

Jesus. This is why no one is buying hemo. They can’t be arsed to read.

THE last time. Zero response now to muppets. Done wasting time replying to intentional tools and daft questions. I’ve responded with humour, sarcasm, disdain and it doesn’t get recognised. Draining and unrewarding.

Ive spent a hundred hours reading HEMO. I share stuff sometimes and no one benefits so it stops. And I learn nothing here. Toxic board.

I’ll be back later on In the year or if someone asks a proper question.